N@N

Madhu Kumar Maintained (APLS) at Strong Buy with Increased Target to $141 on, Apr 14th, 2023

Madhu Kumar of Goldman Sachs, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Strong Buy with Increased Target from $124 to $141 on, Apr 14th, 2023.

Madhu has made no other calls on APLS in the last 4 months.

There are 7 other peers that have a rating on APLS. Out of the 7 peers that are also analyzing APLS, 1 agrees with Madhu's Rating of Hold. Following is the relevant analyst calls for the last 4 months

---

• Derek Archila of "Wells Fargo" Downgraded from Buy to Hold and Held Target at $58 on, Tuesday, January 3rd, 2023

These are the ratings of the 6 analyists that currently disagree with Madhu

---

• Douglas Tsao of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $87 on, Thursday, February 23rd, 2023
• Joseph Stringer of "Needham" Maintained at Strong Buy and Held Target at $80 on, Wednesday, February 22nd, 2023
• Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Increased Target to $139 on, Wednesday, February 22nd, 2023
• Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $91 on, Tuesday, February 21st, 2023
• Annabel Samimy of "Stifel" Maintained at Strong Buy with Increased Target to $75 on, Tuesday, February 21st, 2023
• Colleen Kusy of "Baird" Maintained at Buy with Increased Target to $105 on, Tuesday, February 21st, 2023

Contributing Sources

---